UBS’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $2.78M | Sell |
35,563
-37,793
| -52% | -$2.95M | ﹤0.01% | 1970 |
|
|
2014
Q2 | $4.63M | Buy |
73,356
+16,335
| +29% | +$1.03M | ﹤0.01% | 1582 |
|
|
2014
Q1 | $3.83M | Buy |
57,021
+18,691
| +49% | +$1.25M | ﹤0.01% | 1644 |
|
|
2013
Q4 | $2.47M | Buy |
38,330
+23,420
| +157% | +$1.51M | ﹤0.01% | 1902 |
|
|
2013
Q3 | $954K | Buy |
14,910
+10,649
| +250% | +$681K | ﹤0.01% | 2490 |
|
|
2013
Q2 | $132K | Buy |
+4,261
| New | +$132K | ﹤0.01% | 3648 |
|